{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "New Jersey Weekly Desk", "lead_paragraph": "RISA LAVIZZO-MOUREY was in middle school when she had her first lesson in the economics of health care. The Boeing Company was laying off workers, leaving them without health insurance. Her parents, both doctors practicing in a fairly poor Seattle neighborhood, had to decide each month which patients to bill. ''I asked, 'What does insurance have to do with medical care?' '' Ms. Lavizzo-Mourey recalled recently.", "headline": {"main": "Treating Health Care", "kicker": "IN PERSON"}, "abstract": "Profile of Dr Risa Lavisso-Mourey, geriatric specialist who has been named chief executive of Robert Wood Johnson Foundation; foundation is US's largest philanthropy devoted to health and health care; photo (M)", "print_page": "4", "word_count": 1321, "_id": "4fd289058eb7c8105d85a7e0", "snippet": "RISA LAVIZZO-MOUREY was in middle school when she had her first lesson in the economics of health care. The Boeing Company was laying off workers, leaving them without health insurance. Her parents, both doctors practicing in a fairly poor Seattle...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/10/06/nyregion/in-person-treating-health-care.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "LAVISSO-MOUREY, RISA"}, {"name": "organizations", "value": "JOHNSON, ROBERT WOOD, FOUNDATION"}, {"name": "subject", "value": "APPOINTMENTS AND EXECUTIVE CHANGES"}, {"name": "subject", "value": "BIOGRAPHICAL INFORMATION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Sandra", "lastname": "SALMANS"}], "original": "By SANDRA SALMANS"}, "document_type": "article", "pub_date": "2002-10-06T00:00:00Z", "section_name": "Health; New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Two of the nation's biggest drug companies are cutting back on discounts they promised to low-income elderly people, and other drug makers say they may follow suit. Bristol-Myers Squibb and GlaxoSmithKline said that they had raised the prices they offer in a widely promoted discount program out of concern that federal officials will demand similar deep discounts for the government Medicaid program, which provides health care for the poor.", "headline": {"main": "Drug Makers Cutting Back On Discounts for the Elderly"}, "abstract": "Bristol-Myers Squibb and GlaxoSmithKline cut back on discounts they promised to low-income elderly people, fearing government will demand similar deep discounts for Medicaid program; other drug makers say they may follow suit; federal officials express surprise at moves and say they have not taken any action against discount plans (M)", "print_page": "2", "word_count": 804, "_id": "4fd28c628eb7c8105d860fc0", "snippet": "Two of the nation's biggest drug companies are cutting back on discounts they promised to low-income elderly people, and other drug makers say they may follow suit.    Bristol-Myers Squibb and GlaxoSmithKline said that they had raised the prices they...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/10/05/business/drug-makers-cutting-back-on-discounts-for-the-elderly.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "GLAXOSMITHKLINE PLC"}, {"name": "organizations", "value": "BRISTOL-MYERS SQUIBB CO"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "AGED"}, {"name": "subject", "value": "DISCOUNT SELLING"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2002-10-05T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "As a high-level Egyptian delegation visits Washington this week to discuss increasing American direct investment in Egypt and bolstering the modest $3.1 billion in American-Egyptian trade, a battle is raging here over a new intellectual property rights law, which the United States had said was a prerequisite for a free-trade agreement. At the center of the battle are an American pharmaceuticals giant with a blockbuster drug and a powerful domestic pharmaceuticals industry trying to protect its $5.5 billion turf.", "headline": {"main": "Seeking Investment, Egypt Tries Patent Laws"}, "abstract": "Battle is raging in Egypt over new intellectual property rights law, which US says is prerequisite for free-trade agreement; at center of battle are Pfizer-Egypt, local unit of Pfizer Inc, and powerful domestic pharmaceuticals industry trying to protect its $5.5 billion turf; law has allowed Pfizer to obtain permission from Egyptian government to manufacture and sell its popular impotence drug Viagra in Egypt; local pharmaceutical companies raised storm after exclusive rights were issued to Pfizer in June, accusing ministry of help of helping multinational drug companies to exploit Egypt's poor; Ministry of Health announced two months after Pfizer-Egypt's Viagra was on market that it would authorize 12 local companies to produce generic version of drug to sell at one-twentieth of Pfizer's market price of about $5.20 for each pill; Ministry of Health president Dr Mostafa Ibrahim says ministry's decision does not violate new law, since pharmaceuticals are given grace period until 2005 in developing countries like Egypt; many legal and diplomatic experts dispute Ibrahim, saying protections are already in place; photo (M)", "print_page": "1", "word_count": 1130, "_id": "4fd2207d8eb7c8105d7a400e", "snippet": "As a high-level Egyptian delegation visits Washington this week to discuss increasing American direct investment in Egypt and bolstering the modest $3.1 billion in American-Egyptian trade, a battle is raging here over a new intellectual property...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/10/04/business/seeking-investment-egypt-tries-patent-laws.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "IBRAHIM, MOSTAFA"}, {"name": "glocations", "value": "EGYPT"}, {"name": "organizations", "value": "PFIZER INC"}, {"name": "subject", "value": "COPYRIGHTS"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "SEX"}, {"name": "subject", "value": "INTERNATIONAL TRADE AND WORLD MARKET"}, {"name": "subject", "value": "IMPOTENCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "VIAGRA (DRUG)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Abeer", "lastname": "ALLAM"}], "original": "By ABEER ALLAM"}, "document_type": "article", "pub_date": "2002-10-04T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "As director of hematology at the H\u00f4tel Dieu hospital here, Nicole Casadevall had seen such cases before. A patient in her 60's had developed pure red cell aplasia, in which the body's germ-fighting defenses go haywire and attack its own bone marrow, leaving her severely anemic and facing a lifetime of transfusions to survive. Dr. Casadevall knew of several diseases -- lymphoid cancer, rheumatoid arthritis and systemic lupus -- that could cause red cell aplasia. But this patient had none of them. Indeed, the woman had regularly been injected with a drug to stimulate the production of red blood cells while she received dialysis twice a week. Why, then, was she now unable to make any red blood cells at all?", "headline": {"main": "Mystery Effect In Biotech Drug Puts Its Maker On Defensive"}, "abstract": "Study by Dr Nicole Casadevall, director of hematology at Hotel Dieu, Paris, raises concerns about Johnson & Johnson's anti-anemia drug Eprex and other brands of erythropoietin (EPO), bioengineered protein that is best-selling biotech drug ever; Casadevall found that some patients given drug, which is used to stimulate production of red blood cells, can lose ability to make any red blood cells at all; their antibodies treat drug, which is subtly different from natural protein, as foreign protein and then do same to patients' natural EPO as well; of 141 cases of red aplasia reported in EPO users, most have involved people taking Eprex in Europe, Canada and Australia; only handful of cases have appeared in patients using other brands of drug, including Procrit, Johnson & Johnson's name for EPO drug it sells in US; Johnson & Johnson makes Eprex at factory in Puerto Rico, but Procrit is produced for Johnson & Johnson at factory in Colorado run by Amgen, which developed drug; Johnson & Johnson contends that handful of cases of red cell aplasia in users of its competitors' drugs are evidence that problem, whatever it is, goes beyond Eprex; photo (M)", "print_page": "1", "word_count": 1884, "_id": "4fd28c628eb7c8105d860fe4", "snippet": "As director of hematology at the H\u00f4tel Dieu hospital here, Nicole Casadevall had seen such cases before. A patient in her 60's had developed pure red cell aplasia, in which the body's germ-fighting defenses go haywire and attack its own bone marrow,...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/10/02/business/mystery-effect-in-biotech-drug-puts-its-maker-on-defensive.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CASADEVALL, NICOLE"}, {"name": "glocations", "value": "EUROPE"}, {"name": "glocations", "value": "AUSTRALIA"}, {"name": "glocations", "value": "CANADA"}, {"name": "glocations", "value": "PUERTO RICO"}, {"name": "organizations", "value": "JOHNSON & JOHNSON INC"}, {"name": "organizations", "value": "HOTEL DIEU"}, {"name": "organizations", "value": "AMGEN INC"}, {"name": "subject", "value": "PROCRIT (DRUG)"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ERYTHROPOIETIN (DRUG)"}, {"name": "subject", "value": "EPREX (DRUG)"}, {"name": "subject", "value": "ANEMIA"}, {"name": "subject", "value": "GENETIC ENGINEERING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "John", "lastname": "TAGLIABUE"}], "original": "By JOHN TAGLIABUE"}, "document_type": "article", "pub_date": "2002-10-02T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "''I started doing drugs when I was 13,'' says Suzanne Ferraro, a middle-aged caseworker with a mane of curly hair. Ms. Ferraro sits in the cluttered space that serves as examining room and office for Elaine Kauschinger, the family nurse practitioner who runs the University of Miami School of Nursing's health center at the Agape Women's Center.", "headline": {"main": "Nurses Bridge Cultures to Give Better Care"}, "abstract": "Article on culturally sensitive care, approach to nursing that is finding increasing number of adherents in US; its basic contention is that strictly Western view is inadequate in addressing needs of patients from different cultures and backgrounds; field, in recent years, has expanded to consider spectrum of religious, linguistic, ethnic, economic and gender differences that may affect health care; photo (M)", "print_page": "6", "word_count": 1118, "_id": "4fd289088eb7c8105d85a901", "snippet": "''I started doing drugs when I was 13,'' says Suzanne Ferraro, a middle-aged caseworker with a mane of curly hair.    Ms. Ferraro sits in the cluttered space that serves as examining room and office for Elaine Kauschinger, the family nurse...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/10/01/health/nurses-bridge-cultures-to-give-better-care.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "NURSING AND NURSES"}, {"name": "subject", "value": "IMMIGRATION AND REFUGEES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "MARANTO"}], "original": "By GINA MARANTO"}, "document_type": "article", "pub_date": "2002-10-01T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Low self-esteem is to blame for a host of social ills, from poor academic performance and marital discord to violent crime and drug abuse. Or so goes the gospel, as written over the last several decades by social scientists, self-help book authors and the California Task Force to Promote Self-Esteem and Personal and Social Responsibility, a panel created in 1986 by the California Legislature to conduct a three-year study of the topic.", "headline": {"main": "Deflating Self-Esteem's Role in Society's Ills"}, "abstract": "Article on research by Dr Brad Bushman of Iowa State University and Dr Roy Baumeister of Case Western Reserve University debunking notion that high or low self-esteem results in good or bad behavior; two find that some people with high self-regard are more likely to lash out aggressively when criticized than those with low self-esteem; drawing (M)", "print_page": "1", "word_count": 1521, "_id": "4fd21f888eb7c8105d7a265b", "snippet": "Low self-esteem is to blame for a host of social ills, from poor academic performance and marital discord to violent crime and drug abuse.    Or so goes the gospel, as written over the last several decades by social scientists, self-help book authors...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/10/01/health/deflating-self-esteem-s-role-in-society-s-ills.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSHMAN, BRAD"}, {"name": "persons", "value": "BAUMEISTER, ROY"}, {"name": "organizations", "value": "CASE WESTERN RESERVE UNIVERSITY"}, {"name": "organizations", "value": "IOWA STATE UNIVERSITY"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Erica", "lastname": "GOODE"}], "original": "By ERICA GOODE"}, "document_type": "article", "pub_date": "2002-10-01T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 6, "offset": 0, "time": 179}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}